首页> 外文期刊>Journal of Contemporary Brachytherapy >Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer
【24h】

Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer

机译:颈部颈部患者临床术治疗术治疗术治疗术治疗宫颈癌患者的临床利用分析

获取原文
       

摘要

Introduction To analyze the results of clinical utilization of ring applicator for combined intracavitary (IC)/interstitial (IS) image-guided brachytherapy (BT) technique in locally advanced cervical cancer (LACC), and to explore the application conditions of IC/IS BT approach with this applicator for Chinese patients. Material and methods IC/IS BT was performed in total of 95 LACC patients, who already received external beam radiotherapy. In forty-three of these patients, utilization of ring applicator in brachytherapy was done, including IC/IS BT approach with ring applicator for 65 fractions. Clinically optimized IC/IS BT plan with ring applicator (IC/IS treatment) and additionally generated optimized plan without needle use (IC research) were designed, respectively. Dosage differences in target regions and organs at risk (OARs) were analyzed between both the plans. Four planes were selected in the longitudinal direction of uterine cervix and divided the 360° area around the tandem into eight equal sectors. Tumor target features and prescription dose distributions on different planes were described. Results The usage rate of ring applicator with most suitable ring diameter of 26 mm was 45.3% in Chinese cervical cancer patients. The high-risk clinical target volume (HR-CTV) D90/D98 and intermediate-risk CTV (IR-CTV) D90/D98 in IC/IS treatment were significantly higher than IC research. As compared with IC research plan, the D2.0 cm3 of bladder and rectum in IC/IS treatment were significantly lower (p 0.05). There was no significant difference in D2.0 cm3 of sigmoid and small bowel between two plans. When the target volume was larger than 36 cm3, IC alone had an inadequate coverage of target. Conclusions Nearly half of Chinese patients with LACC could be treated with the ring applicator. The application conditions of IC/IS BT approach with ring applicator for Chinese patients were achieved. Combined IC/IS image-guided BT based on magnetic resonance imaging (MRI) planning is clinically feasible in Chinese patients.
机译:介绍分析局部宫颈癌(LACC)中颈内部(IC)/间质(IC)/间质(IS)图像引导近距离放射治疗(BT)技术的临床利用结果的临床利用结果,并探讨IC /是BT的应用条件用这家申请人为中国患者的方法。材料和方法IC /是BT的总共进行95例LACC患者,他已经接受了外梁放射治疗。在四十三名患者中,完成了近距离放射治疗中的环涂器的利用,包括IC /是BT接近环涂器,用于65个级分。临床优化的IC /是带环涂抹器的BT平面(IC / ARE处理),并且还分别设计了没有针使用(IC研究)的未经针使用的优化计划。在两个计划之间分析了目标区域和风险的器官的剂量差异(桨)。在子宫子宫颈的纵向方向上选择了四个平面,并将360°区域围绕串联分成八个相等的部门。描述了不同平面上的肿瘤靶点和处方剂量分布。结果中文宫颈癌患者,最合适的环直径为26毫米的环涂器的使用率为45.3%。 IC / IC / IS治疗中的高风险临床靶体积(HR-CTV)D90 / D98和中等风险CTV(IR-CTV)D90 / D98显着高于IC研究。与IC研究计划相比,IC /膀胱D2.0 cm3和IC / act的直肠均显着降低(P <0.05)。两个计划之间的D2.0 cm3和小肠中没有显着差异。当目标体积大于36cm 3时,IC单独的占地面积不足。结论近一半的中国LACC患者可以用戒指涂抹器处理。达到了IC / IS的施用条件与中国患者的环涂抹器。合并的IC /是基于磁共振成像的图像引导BT(MRI)规划在中国患者中是临床可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号